Sequential development of ANCA‐associated vasculitis and anti‐GBM disease: A report of two cases

Sequential development of ANCA‐associated vasculitis and anti‐GBM disease: A report of two cases

Abstract In case of AAV with kidney involvement, physicians should explore anti‐GBM antibodies and be aware of the possible sequential development of AAV, especially with MPO‐ANCA, and anti‐GBM glomerulonephritis. This sequential disease history is associated with a poor renal outcome, highlighting...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Camille Le Moine, Noémie Jourde‐Chiche, Delphine Kemlin, Benjamin Terrier, Frédéric Vandergheynst
Natura:	Articolo
Lingua:	English
Pubblicazione:	Wiley 2021-07-01
Serie:	Clinical Case Reports
Soggetti:	ANCA‐associated vasculitis anti‐GBM disease glomerulonephritis myeloperoxidase
Accesso online:	https://doi.org/10.1002/ccr3.4553

Documenti analoghi

Relationship between serologic profile (ANCA type) and clinical features of renal involvement in ANCA-associated vasculitides
di: N M Bulanov, et al.
Pubblicazione: (2018-06-01)

Clinical features and prognosis of MPO-ANCA and anti-GBM double-seropositive patients
di: Xueling Hu, et al.
Pubblicazione: (2022-10-01)

Methimazole-Induced ANCA Vasculitis: A Case Report
di: Precil Diego Miranda de Menezes Neves, et al.
Pubblicazione: (2021-08-01)

ANCA vasculitis in a patient with Alport syndrome: a difficult diagnosis but a treatable disease!
di: Valentine Gillion, et al.
Pubblicazione: (2017-03-01)

Type of ANCA May Be Indispensable in Distinguishing Subphenotypes of Different Clinical Entities in ANCA-Associated Vasculitis
di: Afroditi Maria Konstantouli, et al.
Pubblicazione: (2022-09-01)

Rare case of exostosin 1/exostosin 2-related membranous lupus nephritis concomitant with dual ANCA- and anti-GBM antibody-associated crescentic glomerulonephritis effectively diagnosed by mass spectrometry: a case report
di: Takuya Yamazaki, et al.
Pubblicazione: (2023-07-01)

Interest of a Kidney Biopsy to Rule out ANCA-Associated Renal Vasculitis in Glomerulonephritis Patients with a Positive ANCA
di: Florian Garo, et al.
Pubblicazione: (2022-04-01)

Renal thrombotic microangiopathy in an ANCA-associated vasculitis
di: Ana Teresa Domingos, et al.
Pubblicazione: (2019-10-01)

Pathogenesis and Diagnosis of Otitis Media with ANCA-Associated Vasculitis
di: Naohiro Yoshida, et al.
Pubblicazione: (2014-01-01)

Automated Computational Detection of Disease Activity in ANCA-Associated Glomerulonephritis Using Raman Spectroscopy: A Pilot Study
di: Adam D. Morris, et al.
Pubblicazione: (2022-04-01)

Three Diseases Mediated by Different Immunopathologic Mechanisms—ANCA-Associated Vasculitis, Anti-Glomerular Basement Membrane Disease, and Immune Complex-Mediated Glomerulonephritis—A Common Clinical and Histopathologic Picture: Rapidly Progressive Crescentic Glomerulonephritis
di: Cristina Gluhovschi, et al.
Pubblicazione: (2023-11-01)

An unusual cause of rapidly progressive glomerulonephritis associated with ANCA vasculitis and ovarian malignancy – a relapse 39 years after initial treatment
di: Nikola Simovic, et al.
Pubblicazione: (2023-07-01)

Diagnostic and treatment challenge of unrecognized subacute bacterial endocarditis associated with ANCA-PR3 positive immunocomplex glomerulonephritis: a case report and literature review
di: D. Bele, et al.
Pubblicazione: (2020-01-01)

Comprehensive Analysis of Sex Differences at Disease Manifestation in ANCA-Associated Glomerulonephritis
di: Désirée Tampe, et al.
Pubblicazione: (2021-09-01)

ANCA-associated vasculitis overlaps with systemic sclerosis: a case report and literature review
di: Rui Wu, et al.
Pubblicazione: (2021-03-01)

Treating Patients With ANCA-Associated Vasculitis and Very Severe Renal Injury With an Intensified B Cell Depletion Therapy: Comparison With a Control Cohort Receiving a Conventional Therapy
di: Dario Roccatello, et al.
Pubblicazione: (2022-03-01)

Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival
di: Wei Lin, et al.
Pubblicazione: (2021-03-01)

Complement Inhibition in ANCA-Associated Vasculitis
di: Vladimir Tesar, et al.
Pubblicazione: (2022-07-01)

ANCA-Associated Vasculitis May Result as a Complication to Both SARS-CoV-2 Infection and Vaccination
di: Michalis Christodoulou, et al.
Pubblicazione: (2022-07-01)

Treatment of renal manifestations of ANCA-associated vasculitis
di: Kresimir Galesic, et al.
Pubblicazione: (2013-01-01)

Environmental factors influencing the risk of ANCA-associated vasculitis
di: Wen-Man Zhao, et al.
Pubblicazione: (2022-09-01)

Presentation and progression of MPO-ANCA interstitial lung disease
di: Lorenzo Salvati, et al.
Pubblicazione: (2024-06-01)

Comparative Histological Subtyping of Immune Cell Infiltrates in MPO-ANCA and PR3-ANCA Glomerulonephritis
di: Samy Hakroush, et al.
Pubblicazione: (2021-10-01)

Clinical Phenotype and Outcomes of Indo-Asian Patients with ANCA-Associated Glomerulonephritis in the North West, UK
di: Lauren Floyd, et al.
Pubblicazione: (2023-11-01)

Hypophysitis Secondary to Small Vessel ANCA Vasculitis Treated With Rituximab
di: Nankee K. Kumar, AB, et al.
Pubblicazione: (2024-03-01)

ANCA-associated vasculitis in a 14 years-old patient: a clinical case
di: A. V. Burlutskaya, et al.
Pubblicazione: (2020-10-01)

A case of COVID‐19‐associated C‐ANCA vasculitis, was successfully treated with rituximab therapy
di: Michael Filoramo, et al.
Pubblicazione: (2024-08-01)

Newly diagnosed ANCA-associated vasculitis after COVID-19 infection: a case report
di: Kazuhiro Kitamoto, et al.
Pubblicazione: (2023-08-01)

Altered circulating CCR6+and CXCR3+ T cell subsets are associated with poor renal prognosis in MPO-ANCA-associated vasculitis
di: Zhonghua Liao, et al.
Pubblicazione: (2021-07-01)

Update of Management of ANCA-Associated Vasculitis
di: Hoi San Tang, et al.
Pubblicazione: (2021-12-01)

Blue toe syndrome as the initial manifestation of ANCA-associated vasculitis
di: Marinchev Liubomir, et al.
Pubblicazione: (2013-10-01)

Hypocomplementemia is associated with more severe renal disease and worse renal outcomes in patients with ANCA-associated vasculitis: a retrospective cohort study
di: Aglaia Chalkia, et al.
Pubblicazione: (2020-01-01)

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
di: Zachary S. Wallace, et al.
Pubblicazione: (2019-12-01)

Rapidly progressive glomerulonephritis and ANCA-negative pauci-immune vasculitis: an unusual presentation. A case report
di: Zitlali Guadalupe Paulín Zepeda, et al.
Pubblicazione: (2023-09-01)

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and fibromyalgia: PR3-versus MPO-ANCA-associated vasculitis, an exploratory cross-sectional studyResearch in context
di: Charmaine van Eeden, et al.
Pubblicazione: (2023-04-01)

Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients
di: Laura S. van Dam, et al.
Pubblicazione: (2020-12-01)

Rituximab induction therapy for de novo ANCA associated vasculitis in pregnancy: a case report
di: Claire Harris, et al.
Pubblicazione: (2018-06-01)

Impact of ANCA-Associated Vasculitis on Outcomes of Hospitalizations for Goodpasture’s Syndrome in the United States: Nationwide Inpatient Sample 2003–2014
di: Charat Thongprayoon, et al.
Pubblicazione: (2020-03-01)

ANCA-associated Leucocytoclastic Vasculitis presenting with Bronchiectasis, GI Involvement and Hypertensive Urgency: A Complex Case without Renal Involvement
di: N. M. M. Risly, et al.
Pubblicazione: (2024-12-01)

Association of TERT and DSP variants with microscopic polyangiitis and myeloperoxidase-ANCA positive vasculitis in a Japanese population: a genetic association study
di: Aya Kawasaki, et al.
Pubblicazione: (2020-10-01)